NCT02999009View on ClinicalTrials.gov

Trident II Tritanium Acetabular Shell Outcomes Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

January 20, 2017

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2031

Conditions
Arthroplasty, Replacement, Hip
Interventions
DEVICE

Trident II Tritanium Acetabular Shell

A hemispherical acetabular shell indicated for cementless application.

Trial Locations (9)

10021

Hospital for Special Surgery, New York

10075

Northwell Health, Lenox Hill Hospital, New York

27599

UNC Orthopaedics, Chapel Hill

32204

Southeast Orthopedic Specialists, Jacksonville

48197

St. Joseph Mercy Hospital Health System, Ypsilanti

60018

American Hip Institute, Des Plaines

70605

Center for Orthopaedics and Spine, LLC, Lake Charles

85712

Tucson Orthopaedic Institute, Tucson

08234

Rothman Institute, Egg Harbor

All Listed Sponsors
lead

Stryker Orthopaedics

INDUSTRY

NCT02999009 - Trident II Tritanium Acetabular Shell Outcomes Study | Biotech Hunter | Biotech Hunter